226 results
Posted on 30.05.2011
Changing environment for medical device companies? Differentiate now or fail later
Korn/Ferry International and Eucomed are co-organising the upcoming “How to differentiate in a changing environment?” conference taking place on 5 July 2011 in Brussels. We have worked closely together to design an exciting programme that will give participants a broad view on the future from a health economic point of view, but the various sessions will also discuss what hospitals are looking for from medical device companies. In addition, we have invited accomplished speakers representing other industries’ perspectives and experiences. In short, this meeting is designed to allow the exchange of experience and ideas, and see what is done in other industries to help medical device companies enhance their competitiveness and remain healthy businesses.
To the MedTech industry: don’t stick to old-fashioned business models when talking about the value of your technologies
Medicine became evidence-based a long time ago and rightfully so. So why is it that policy decisions are, still today, far from evidence-based in Europe? Why are healthcare managers and decision makers still relying upon short-term cost containment objectives when it comes to access, regulation and evaluation of new technologies?
Posted on 01.04.2011
UDI, GS1, GTIN, GHTF, ETF, EHR, ISMP… What does it mean to me and to you?
Having been involved with the medical devices industry for many years, I’ve seen how the industry has evolved using innovative solutions and has constantly embraced technological developments. Recently however I had a friend on the receiving end of this technology and I hope you find his ‘patient case report’ below of interest – do note he also works in the medtech industry hence his knowledge on this subject…
Posted on 17.02.2011
Who wants to save €5.6 billion? Telemonitoring and eHealth: more than fancy gadgetry
Eucomed has recently submitted remote monitoring of implantable cardiac devices as one of its four proposals to the Active and Healthy Ageing Innovation Partnership under the European Commission’s Innovation Union Strategy. Such an initiative is exactly what Europe is in need of to ensure its place at the top of the innovation ladder. Eucomed selected […]
Posted on 08.02.2011
Brussels starts healthy debate on Medical Device Recast
Recent events in Brussels are pointing to a fresh, healthy airing of views and more robust debate on the Recast. (By the way, I’ve noticed that everybody says ‘Recast’ but not too many people know what a ‘Recast’ is. So for all those legal and regulatory ‘techies’ among you, click here, all others steer clear!). […]
Posted on 04.02.2011
Cheap trumps innovativeness… or not?
As I was commuting back to Brussels last week, a copy of The Economist laid out in front of me, my eye was immediately drawn to the title of that week’s Leader. Who wouldn’t be inclined to read on when an enticing header such as “Life should be cheap” is staring right at you. Intrigued […]
What is value in healthcare?
When one of the defining minds of business education in recent years turns his attention to healthcare then people would be wise to sit up and listen. Harvard Business School guru Michael Porter first entered the impenetrable world of health policy in 2006 in a book with colleague Elizabeth Teisberg entitled ‘Redefining health care: creating […]
Posted on 08.12.2010
The potential role of home monitoring devices in active and healthy ageing
As one of the baby boomers and firmly fingered with responsibility for both the healthcare funding and pensions crises, it is with a very personal interest that I look at emerging trends in care of the chronically sick and ageing. Age unfortunately means collecting co-morbidities, hopefully minor ones, and dealing with them in a way […]
There’s a good future in (DG) Research
In a time when much health industry focus is on the European Commission’s Health Directorate, DG SANCO, EU Commissioner for Research Máire Geoghegan-Quinn chose Covidien’s 20 year celebration of their Galway, Ireland, facility (congratulations to all at Covidien) to emphasise again the value of the Medical Technology industry to Europe and the huge policy and funding support that she and her Directorate, DG Research, provide to the sector.